Form 4: Zura Bio Ltd. Grants Share Options to Graham Neil Murray Hamilton

Zura Bio Ltd. has granted 117,000 share options to Graham Neil Murray Hamilton, vesting over one year.

Summary

• Zura Bio Ltd. granted 117,000 share options to Graham Neil Murray Hamilton on December 9, 2024.
• The options have an exercise price of $2.76 per share.
• These options vest in twelve equal monthly installments over a one-year period, starting from October 23, 2024.
• Any remaining unvested options will vest the day before the next annual shareholder meeting, provided Mr. Hamilton is still employed.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of equity compensation, which is generally positive for aligning employee and company interests. There are no negative implications.

Positives

• The share option grant aligns Mr. Hamilton's interests with the company's performance.
• The vesting schedule encourages continued service and contribution from Mr. Hamilton.

Future Outlook

The vesting of the options is contingent on continued service, suggesting an expectation of ongoing contribution from Mr. Hamilton.

Industry Context

Share option grants are a common practice in the biotechnology industry to incentivize key personnel.

Comparison to Industry Standards

• Share option grants are a standard form of compensation in the biotech industry, often used to attract and retain talent.
• Vesting schedules, such as the one-year monthly vesting in this case, are typical to ensure long-term commitment from employees.
• The exercise price of $2.76 is specific to Zura Bio's valuation and may be compared to similar grants at comparable biotech companies.

Stakeholder Impact

• Shareholders may view this as a positive step in retaining key personnel.
• Employees may see this as a positive sign of the company's commitment to its team.

Key Dates

Keywords

Share Options, Equity Compensation, Vesting, Zura Bio Ltd, Graham Neil Murray Hamilton